You have 9 free searches left this month | for more free features.

Camptothecin

Showing 1 - 25 of 166

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Urothelial Carcinoma, Urothelial Cancer, Lung Tumors Trial run by the NCI (EP0057, olaparib)

Recruiting
  • Urothelial Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Adult Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Irinotecan Hydrochloride)

Active, not recruiting
  • Adult Solid Neoplasm
  • Erlotinib Hydrochloride
  • Irinotecan Hydrochloride
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Metastatic Castration Resistant Prostate Cancer, Prostate Tumors Trial run by the NCI (enzalutamide, CRLX101)

Terminated
  • Metastatic Castration Resistant Prostate Cancer
  • Prostate Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 16, 2022

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Active, not recruiting
  • Recurrent Anaplastic Astrocytoma
  • +6 more
  • Carboxylesterase-expressing Allogeneic Neural Stem Cells
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8 Trial in Houston

Active, not recruiting
  • Metastatic Colorectal Carcinoma
  • +4 more
  • Cetuximab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 4, 2022

BRAF NP_004324.2:p.V600X, KRAS wt Allele, Metastatic Malignant Solid Tumor Trial in Houston (biological, drug, other)

Active, not recruiting
  • BRAF NP_004324.2:p.V600X
  • +6 more
  • Cetuximab
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Metastatic Ewing Sarcoma, Recurrent Ewing Sarcoma Trial in Houston (Fine-Needle Aspiration, Irinotecan, Irinotecan

Withdrawn
  • Metastatic Ewing Sarcoma
  • Recurrent Ewing Sarcoma
  • Fine-Needle Aspiration
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)

Recruiting
  • Pancreas Cancer
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Aug 19, 2022

Advanced Bile Duct Carcinoma, Advanced Gallbladder Carcinoma, Refractory Bile Duct Carcinoma Trial in Rochester (Irinotecan,

Active, not recruiting
  • Advanced Bile Duct Carcinoma
  • +17 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 5, 2023

Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
  • +1 more
Sep 16, 2022

Pancreas Cancer, Adenocarcinoma of the Pancreas Trial in Omaha (Digoxin, 5Fluorouracil, Calcium Leucovorin)

Recruiting
  • Pancreas Cancer
  • Adenocarcinoma of the Pancreas
  • Omaha, Nebraska
    University of Nebraska Medical Center
Mar 31, 2022

Borderline Resectable Pancreatic Carcinoma, Locally Advanced Unresectable Pancreatic Adenocarcinoma, Resectable Pancreatic

Recruiting
  • Borderline Resectable Pancreatic Carcinoma
  • +8 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Aug 25, 2022

Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan

Active, not recruiting
  • Childhood Solid Neoplasm
  • +4 more
  • Irinotecan Hydrochloride
  • +4 more
  • Birmingham, Alabama
  • +20 more
Feb 1, 2023

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Detroit (biological,

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Aldesleukin
  • +9 more
  • Detroit, Michigan
    Wayne State University/Karmanos Cancer Institute
Mar 30, 2022

CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Not Otherwise Specified, CNS Ganglioneuroblastoma Trial in

Active, not recruiting
  • Central Nervous System Embryonal Tumor With Rhabdoid Features
  • +14 more
  • Birmingham, Alabama
  • +23 more
Oct 7, 2022

Solid Tumors, Primary Brain Tumors Trial in United States (Vincristine, Irinotecan, Temozolomide)

Completed
  • Solid Tumors
  • Primary Brain Tumors
  • Hartford, Connecticut
  • +13 more
Jan 12, 2023

Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Solid Tumor, Metastatic Neuroendocrine Carcinoma Trial in United

Recruiting
  • Metastatic Lung Small Cell Carcinoma
  • +16 more
  • Phoenix, Arizona
  • +10 more
Mar 25, 2022

Colorectal Cancer Metastatic Trial in Guangzhou (Cetuximab, Irinotecan, Vemurafenib)

Recruiting
  • Colorectal Cancer Metastatic
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Mar 7, 2021

Solid Tumor Trial in Cincinnati (Bevacizumab, Temozolomide, Vincristine)

Completed
  • Solid Tumor
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Feb 8, 2021

Advanced Colorectal Carcinoma, Advanced Digestive System Carcinoma, Advanced Gastric Carcinoma Trial in United States

Recruiting
  • Advanced Colorectal Carcinoma
  • +42 more
  • Duarte, California
  • +9 more
Jan 21, 2023

Metastatic Colorectal Carcinoma, Metastatic Lung Carcinoma, Metastatic Lung Small Cell Carcinoma Trial in United States

Recruiting
  • Metastatic Colorectal Carcinoma
  • +29 more
  • Los Angeles, California
  • +22 more
Jun 28, 2022

Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +28 more
  • Conroe, Texas
  • +4 more
Dec 5, 2022

Ewing Sarcoma, Ewing Family of Tumors, Ewing's Tumor Metastatic Trial in United States (Vigil, Irinotecan, Temozolomide)

Active, not recruiting
  • Ewing Sarcoma
  • +12 more
  • Vigil
  • +2 more
  • Little Rock, Arkansas
  • +16 more
Feb 9, 2022

Stage IV Colorectal Cancer Trial in Philadelphia (Ascorbic Acid, Irinotecan)

Terminated
  • Stage IV Colorectal Cancer
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Jun 30, 2020